Methods for Measuring Crystallization in Urolithiasis Research: Why, How and When?

Whereas crystalluria does not distinguish between kidney stone formers and healthy people and thus can be considered a physiologic event, kidney stone formation is a pathologic incident and reflects a specific form of biomineralization. Both single urinary crystals as well as whole kidney stones form under exquisite control of organic macromolecules. Simple crystal formation in the urinary tract is distinguished from stone formation in the kidney by the process of particle retention. The latter occurs either because nucleated crystals strongly aggregate to particles too large to pass freely through the tubules (‘free particle’ theory), or because crystals become abnormally adherent to tubular cell surfaces (‘fixed particle’ theory). Since it is impossible to mimic all the processes involved in stone formation in vitro, it is highly important to carefully chose a specific crystallization process for in vitro studies, and to select the most appropriate experimental conditions for measuring the chosen process as reliably as possible. This overview aims at critically reviewing the principles of currently available assay systems for studying crystallization processes involved in stone formation. Consensus is reached by the experts that no in vitro system really mimics what happens in renal stone formation, but that carefully designed in vitro studies will always play an important part in urolithiasis research. For such studies, it is highly important to exactly control the appropriate experimental conditions that are relevant to a specific crystallization process under investigation. Practical guidelines for researchers working with crystallization systems are provided, and it is concluded that international efforts should be made to standardize the terminology, to agree on a set of basic experimental parameters (temperature, pH, artificial urine composition), and to adopt simple tests or conditions are reference points for quality and comparative control.

[1]  J. Ľupták,et al.  Crystallization of Calcium Oxalate and Calcium Phosphate at Supersaturation Levels Corresponding to Those in Different Parts of the Nephron , 2021 .

[2]  H. Tiselius Measurement of the risk of calcium phosphate crystallization in urine , 2004, Urological Research.

[3]  R. Ryall,et al.  Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. , 1999, European journal of biochemistry.

[4]  R. Ryall,et al.  Minerals in animals and vegetables , 1998 .

[5]  G. Parkinson Crystal-macromolecule interactions in urolithiasis: lessons from healthy biomineralization systems. , 1998, Current opinion in urology.

[6]  Saeed R. Khan Tubular cell surface events during nephrolithiasis , 1997 .

[7]  Saeed R. Khan,et al.  Interactions between stone-forming calcific crystals and macromolecules. , 1997, Urologia internationalis.

[8]  R. Moritz,et al.  The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. , 1995, Clinical science.

[9]  H. Tiselius,et al.  Crystallization properties in urine from calcium oxalate stone formers. , 1995, The Journal of urology.

[10]  F. Schröder,et al.  Association of calcium oxalate monohydrate crystals with MDCK cells. , 1995, Kidney international.

[11]  D. Kok,et al.  Calcium oxalate nephrolithiasis, a free or fixed particle disease. , 1994, Kidney international.

[12]  Tiselius Hg Investigation of single and recurrent stone formers. , 1994 .

[13]  H. Tiselius Investigation of single and recurrent stone formers. , 1994, Mineral and electrolyte metabolism.

[14]  F. Schröder,et al.  A review of new concepts in renal stone research. , 1993, Scanning microscopy.

[15]  J. Lieske,et al.  Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. , 1993, The American journal of physiology.

[16]  J. Garside,et al.  Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer. , 1993, The Journal of urology.

[17]  Kavanagh Jp Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research. , 1992 .

[18]  J. Kavanagh Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research. , 1992, Scanning microscopy.

[19]  J. Parks,et al.  Protein inhibitors of crystallization. , 1991, Seminars in nephrology.

[20]  F. Coe,et al.  Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. , 1989, The American journal of physiology.

[21]  R. Ryall,et al.  The Effect of Macromolecules on the Crystallization of Calcium Oxalate in Human Urine , 1989 .

[22]  M. Resnick,et al.  Urinary stone matrix. , 1988, The Journal of urology.

[23]  C. Pak,et al.  A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. , 1983, Metabolism: clinical and experimental.

[24]  G. H. Nancollas,et al.  Effects of urine pretreatment on calcium oxalate crystallization inhibition potentials. , 1983, The Journal of urology.

[25]  A. Boskey Current concepts of the physiology and biochemistry of calcification. , 1981, Clinical orthopaedics and related research.

[26]  R. Ryall,et al.  The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[27]  W. Robertson,et al.  Factors influencing the crystallisation of calcium oxalate in urine - critique , 1981 .

[28]  J. Garside,et al.  The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents. , 1981, Investigative urology.

[29]  H. Tiselius,et al.  Evaluation of a routine method for determination of calcium oxalate crystal growth inhibition in diluted urine samples. , 1981, Clinical chemistry.

[30]  A. Randolph,et al.  A Proposal of Standardized Nomenclature in the Study of Crystallization in Biological Systems, e.g. Urolithiasis , 1981 .

[31]  B. Finlayson,et al.  Urolithiasis, clinical and basic research , 1981 .

[32]  W. Gill,et al.  Elevation of the metastable limits and absence of container surface nucleation for calcium oxalate crystallization in a urothelial-lined system as compared to glass containers. , 1980, Investigative urology.

[33]  J. Burns,et al.  A proposal for a standard reference artificial urine in in vitro urolithiasis experiments. , 1980, Investigative urology.

[34]  H. Fleisch Inhibitors and promoters of stone formation. , 1978, Kidney international.